Michael A. Mussallem - 01 Oct 2021 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
Chairman & CEO, Director
Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
01 Oct 2021
Net transactions value
-$2,656,087
Form type
4
Filing time
01 Oct 2021, 21:06:56 UTC
Previous filing
16 Sep 2021
Next filing
09 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $980,288 +45,050 +24% $21.76 233,052 01 Oct 2021 Direct F1
transaction EW Common Stock Sale $33,930 -300 -0.13% $113.10 232,752 01 Oct 2021 Direct F1, F2
transaction EW Common Stock Gift $0 -12,500 -5.4% $0.000000 220,252 01 Oct 2021 Direct
transaction EW Common Stock Sale $1,585,186 -14,132 -6.4% $112.17 206,120 01 Oct 2021 Direct F1, F3
transaction EW Common Stock Sale $2,017,258 -18,118 -8.8% $111.34 188,002 01 Oct 2021 Direct F1, F4
transaction EW Common Stock Gift $0 +12,500 +0.39% $0.000000 3,210,287 01 Oct 2021 By Living Trust
holding EW Common Stock 371,726 01 Oct 2021 401(k) F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -45,050 -12% $0.000000 315,350 01 Oct 2021 Common Stock 45,050 $21.76 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $112.9700 to $113.3250. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $111.6600 to $112.6200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $110.6400 to $111.6400. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F5 Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.